Page last updated: 2024-08-17

chloramphenicol and probenecid

chloramphenicol has been researched along with probenecid in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-199015 (48.39)18.7374
1990's1 (3.23)18.2507
2000's8 (25.81)29.6817
2010's6 (19.35)24.3611
2020's1 (3.23)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Topliss, JG; Yoshida, F1
Chang, TK; Ensom, MH; Kiang, TK1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Christensen, LK; Hansen, JM1
Thatcher, RW1
Berger, W1
Odar-Cederlöf, I; Säwe, J; von Bahr, C; Yue, Q1
Willcox, RR1
Fabre, J; Herrera, A; Perrin, L; Petitpierre, B; Rudhardt, M1
Broughton, W; Goldman, JN1
Fabre, J; Perrin, L; Petitpierre, B; Rudhardt, M1
Sim, SK1
Graber, CD; Jervey, LP; Ostrander, WE; Salley, LH; Weaver, RE1
Beaty, HN; Petersdorf, RG; Turck, M1
Hedström, SA1
Germer, S; Shann, F2
SILBERSTEIN, EB1
BEATTY, JO; BOGER, WP; MATTEUCCI, WV1

Reviews

5 review(s) available for chloramphenicol and probenecid

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Pharmacology & therapeutics, 2005, Volume: 106, Issue:1

    Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic

2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Drugs, 1977, Volume: 13, Issue:1

    Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide

1977
A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia.
    The British journal of venereal diseases, 1970, Volume: 46, Issue:3

    Topics: Anti-Bacterial Agents; Asia, Southeastern; Chloramphenicol; Erythromycin; Female; Gonorrhea; Humans; Injections; Male; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Probenecid; Spectinomycin; Sulfathiazoles; Sulfonamides; Tetracycline

1970

Other Studies

26 other study(ies) available for chloramphenicol and probenecid

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Treatment of acute gonococcal conjunctivitis.
    Annals of ophthalmology, 1978, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Chloramphenicol; Conjunctivitis; Corneal Ulcer; Drug Administration Schedule; Drug Therapy, Combination; Female; Gonorrhea; Humans; Infant, Newborn; Male; Ophthalmia Neonatorum; Penicillin G Procaine; Probenecid; Tetracyclines

1978
[Interactions between oral antidiabetics and other drugs].
    Therapeutische Umschau. Revue therapeutique, 1976, Volume: 33, Issue:9

    Topics: Chloramphenicol; Coumarins; Drug Interactions; Humans; Hypoglycemic Agents; Probenecid; Sulfonamides

1976
Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors.
    Pharmacology & toxicology, 1990, Volume: 66, Issue:3

    Topics: Adult; Amitriptyline; Chloramphenicol; Codeine; Diazepam; Glucuronates; Glucuronosyltransferase; Humans; In Vitro Techniques; Kidney; Kinetics; Microsomes; Microsomes, Liver; Morphine; Oxazepam; Probenecid

1990
Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy.
    International journal of clinical pharmacology, therapy and toxicology, 1972, Volume: 6, Issue:2

    Topics: Acenocoumarol; Allopurinol; Chloramphenicol; Chlorpropamide; Clofibrate; Glomerular Filtration Rate; Glomerulonephritis; Half-Life; Humans; Kidney; Kidney Diseases; Probenecid; Pyelonephritis

1972
The intraocular penetration of chloramphenicol succinate in rabbits.
    Annals of ophthalmology, 1973, Volume: 5, Issue:1

    Topics: Ampicillin; Animals; Aqueous Humor; Biological Assay; Chloramphenicol; Conjunctiva; Eye; Injections; Injections, Intramuscular; Injections, Intraperitoneal; Probenecid; Rabbits; Streptococcus; Time Factors

1973
[Behavior of chlorpropamide in nephropathies in the presence of associated drugs].
    Helvetica medica acta, 1972, Volume: 36, Issue:2

    Topics: Allopurinol; Chloramphenicol; Chlorpropamide; Chromium Isotopes; Humans; Kidney Diseases; Probenecid

1972
Chemotherapy of gonorrhea: a review of current status.
    Canadian Medical Association journal, 1972, Nov-18, Volume: 107, Issue:10

    Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Erythromycin; Gonorrhea; Humans; Kanamycin; Penicillins; Probenecid; Rifampin; Sulfonamides; Trimethoprim

1972
Endocarditis due to a lanthanic, unclassified Gram-negative bacterium (group IV d).
    American journal of clinical pathology, 1968, Volume: 49, Issue:2

    Topics: Adult; Ampicillin; Bacteria; Chloramphenicol; Endocarditis, Bacterial; Humans; Male; Penicillin G; Penicillin Resistance; Probenecid; Sepsis

1968
Activity of broad-spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis.
    Annals of the New York Academy of Sciences, 1967, Sep-27, Volume: 145, Issue:2

    Topics: Administration, Oral; Ampicillin; Cephaloridine; Cephalothin; Chloramphenicol; Endocarditis, Bacterial; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Microbial Sensitivity Tests; Penicillin G; Probenecid; Streptococcus; Streptomycin; Tetracycline; Time Factors

1967
General and local antibiotic treatment of chronic osteomyelitis.
    Scandinavian journal of infectious diseases, 1969, Volume: 1, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Sedimentation; C-Reactive Protein; Child; Chloramphenicol; Chronic Disease; Cloxacillin; Colistin; Female; Fistula; Humans; Injections; Male; Middle Aged; Osteomyelitis; Probenecid; Prognosis; Recurrence; Staphylococcal Infections; Staphylococcus

1969
Treatment of bacterial meningitis without intravenous fluids.
    The Medical journal of Australia, 1983, Apr-02, Volume: 1, Issue:7

    Topics: Chloramphenicol; Drug Therapy, Combination; Humans; Meningitis, Haemophilus; Penicillins; Probenecid

1983
Treatment of bacterial meningitis in children without intravenous fluids.
    The Medical journal of Australia, 1981, May-30, Volume: 1, Issue:11

    Topics: Administration, Oral; Anti-Bacterial Agents; Chloramphenicol; Humans; Infant; Injections, Intramuscular; Meningitis; Penicillin G; Probenecid; Prospective Studies

1981
ERYSIPELOTHRIX ENDOCARDITIS: REPORT OF A CASE WITH CEREBRAL MANIFESTATIONS.
    JAMA, 1965, Mar-08, Volume: 191

    Topics: Brain Diseases; Chloramphenicol; Chlorothiazide; Digoxin; Diuretics; Drug Therapy; Endocarditis; Endocarditis, Bacterial; Erysipelothrix; Heart Failure; Heart Valve Diseases; Humans; Methicillin; Organomercury Compounds; Penicillin V; Penicillins; Probenecid; Sepsis

1965
'Benemid' p-(di-n-propylsulfamyl)-benzoic acid; lack of effect of aureomycin, chloromycetin, streptomycin and terramycin.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1951, Volume: 76, Issue:2

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Benzoic Acid; Chloramphenicol; Chlortetracycline; Dermatologic Agents; Oxytetracycline; Probenecid; Streptomycin

1951